Pet Diabetes Care Market Report
RA00708
Pet Diabetes Care Market by Animal Type (Dogs and Cats), Solution (Treatment and Glucose Monitoring Devices), Distribution Channel (Veterinary Hospitals & Clinics, Retail Pharmacies, and E-commerce), and Region (North America, Europe, Asia-Pacific, and LAMEA): Opportunity Analysis and Industry Forecast, 2023-2032
Pet Diabetes Care Overview
The pet diabetes care market is a specialized section under the broader animal fitness industry that focuses on the diagnosis and treatment. Diabetes mellitus, a persistent ailment characterized by excessive blood glucose levels, can affect dogs and cats, requiring committed care and attention to ensure their well-being. The market for pet diabetes care has witnessed a significant growth due to several factors. Firstly, the increasing occurrence of diabetes in pets has pushed the demand for dedicated healthcare services. Factors such as sedentary lifestyles, obesity, genetic predisposition, and certain scientific stipulations make a contribution to the development of diabetes in pets. Pet owners are becoming more conscious of the signs and symptoms of diabetes and are seeking perfect diagnosis and treatment for their diabetic pets, leading to the growth of the market.
Global Pet Diabetes Care Market Analysis
The global pet diabetes care market size was $1,745.80 million in 2022 and is predicted to grow at a CAGR of 6.8%, by generating a revenue of $3,310.26 million by 2032.
COVID-19 Impact on Global Pet Diabetes Care Market
The pandemic posed challenges for the pet diabetes care market. The lockdowns imposed during the pandemic impacted routine veterinary care, together with the diagnosis of persistent stipulations like diabetes. Non-emergency approaches and appointments were postponed or cancelled, reducing the number of pet owners getting admission to well-timed and comprehensive diabetes care for their pets.
Furthermore, the financial influence of the pandemic has had a mixed impact on the market. Financial uncertainties and constraints experienced by pet owners may have led to decreased spending on pet healthcare, such as diabetes care. This may have affected the adoption of advanced diagnostics, medications, and specialized diets for diabetic pets.
The Increasing Prevalence of Diabetes in Pets to Drive the Market Growth
The growing prevalence of diabetes in pets is one of the important drivers of the global pet diabetes care market. Diabetes mellitus, a chronic situation characterized through high blood glucose levels, affects a sizeable range of dogs and cats worldwide. The rising incidence of diabetes in pets can be attributed to elements such as sedentary lifestyles, obesity, genetic predisposition, and certain clinical conditions. This growing occurrence has created a greater demand for specialized diagnosis and treatment of diabetes in pets. Pet owners are slowly becoming conscious of the signs and symptoms of diabetes and are in search of veterinary care to ensure their pets' well-being. This increased cognizance and demand for pet diabetes care has contributed to the market's growth, driving the development of innovative products, diagnostic tools, and cure options to efficiently control this chronic condition in pets.
Cost Associated with Diabetes Management for Pets to Restrain Market Growth
One important difficulty that can restrain the market growth of the global pet diabetes care market is the cost of diabetes management for pets. Providing comprehensive care for diabetic pets, including normal veterinary visits, diagnostic tests, medications, specialized diets, and monitoring supplies, can be expensive. The ongoing nature of diabetes management requires long-term commitment from pet owners. This cost component may limit accessibility to effective diabetes care for some pet owners, specifically those dealing with monetary constraints. The high costs associated with pet diabetes care can act as a barrier to treatment and may additionally discourage pet owners from searching for perfect management for their diabetic pets. It is vital for the industry to address this difficulty by using exploring cost-efficient solutions, merchandising insurance for pets, and raising consciousness about the long-term advantages of investing in diabetes administration for better pet fitness outcomes.
Advancements in Technology to Drive Excellent Opportunities
Advancements in technology have created significant opportunities for the global pet diabetes care market. These technological improvements have the potential to revolutionize the way diabetes is diagnosed, monitored, and controlled in pets. One huge opportunity lies in the development of superior diagnostic tools for early and correct detection of diabetes in pets. Technological developments have led to the availability of sophisticated blood glucose monitoring systems, continuous glucose monitoring devices, and point-of-care testing devices. These tools allow veterinarians and pet owners to monitor glucose levels in real-time, allowing for well-timed adjustments in diagnosis plans and better diabetes treatment.
Global Pet Diabetes Care Market Share, by Animal Type, 2022
The dogs sub-segment accounted for the highest market share in 2022. Dogs are dominating the global pet diabetes care market due to quite a few key factors. Firstly, dogs have a greater incidence of diabetes compared to other pets. Factors such as breed predisposition, genetic factors, obesity, and age contribute to the higher incidence of diabetes in dogs. As a result, there is a higher demand for diabetes care products, diagnostics, and administration strategies especially tailor-made for dogs.
Global Pet Diabetes Care Market Share, by Solution, 2022
The treatment sub-segment accounted for the highest market share in 2022. Treatment solutions are dominating the global pet diabetes care market due to their vital role in controlling diabetes in pets effectively. These remedial solutions encompass a variety of medications, insulin therapies, dietary modifications, and lifestyle management techniques that aim to regulate blood glucose levels and improve the general fitness of diabetic pets. One of the key elements driving the dominance of treatment solutions in the market is the chronic nature of diabetes in pets. Diabetes requires continuous diagnosis and treatment to maintain optimal blood glucose levels and avoid complications. Treatment solutions, inclusive of insulin therapy, oral medications, and other adjunct therapies, are crucial for reaching glycemic control in diabetic pets. These solutions help alter blood glucose levels, limit clinical signs of diabetes, and improve the well-being of the animals.
Global Pet Diabetes Care Market Share, by Distribution Channel, 2022
The veterinary hospitals & clinics sub-segment garnered the maximum revenue in 2022. With the growing incidence of diabetes in pets and the developing demand for specialized care, these amenities have strategically positioned themselves to cater to the demands of diabetic pets and their owners. One key component contributing to their dominance is their complete approach to pet healthcare. Veterinary hospitals & clinics provide a vast variety of services, such as diagnostics, treatment, monitoring, and regular management of diabetes in pets. This integrated approach allows pet owners to access all the fundamental assets and know-how beneath one roof, thus fulfilling the entire gamut of demands satisfactorily.
Global Pet Diabetes Care Market Share, by Region, 2022
The Asia-Pacific region accounted for the largest market share in 2022. With a growing pet populace and increasing awareness about pet health, the demand for diabetes care products and services has witnessed substantial growth in this region. Several factors contribute to the expanding market share of Asia Pacific in the pet diabetes care market. Firstly, the region's rising disposable income and improving living standards have led to higher spending on pet healthcare. As pet owners become more aware of their pets' well-being, they are inclined to make investments in specialized care, such as diabetes monitoring and treatment.
Competitive Scenario in the Global Pet Diabetes Care Market
Strategic acquisitions, partnerships, and geographic expansion through setting up new facilities are the leading strategies adopted by the industry players to increase their footprint in the global pet diabetes care market.
Leading companies such as Merck & Co., Inc., Zoetis, BD, Boehringer Ingelheim International GmbH, Trividia Health, Inc., Allison Medical, Inc., UltiMed, Inc., ACON Laboratories Inc., i-SENS, Inc., TaiDoc Technology Corporation are at the forefront of this competitive landscape. These companies have established themselves as outstanding players in the market, imparting a complete portfolio of options for pet diabetes care.
| Aspect | Particulars |
| Historical Market Estimations | 2021 |
| Base Year for Market Estimation | 2022 |
| Forecast Timeline for Market Projection | 2023-2032 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by Animal Type |
|
| Segmentation by Solution |
|
| Segmentation by Distribution Channel |
|
| Key Companies Profiled |
|
Q1. What is the size of the pet diabetes care market?
A. The size of the pet diabetes care market was over $1,745.80 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 6.8% from 2023 to 2032.
Q2. Which are the major companies in the pet diabetes care market?
A. Merck & Co., Inc., Zoetis, and BD are some of the key players in the global Pet Diabetes Care market.
Q3. Which region, among others, possesses greater investment opportunities in the near future?
A. Asia-Pacific region possesses great investment opportunities for investors to witness the most promising growth in the future.
Q4. What are the strategies opted by the leading players in this market?
A. Strategic acquisitions, partnerships, and geographic expansion and market penetration are the key strategies opted by the operating companies in this market.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Pet Diabetes Care Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Pet Diabetes Care Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Pet Diabetes Care Market, By Product
5.1. Overview
5.2 Insulin Therapy
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Oral Therapy
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Research Dive Exclusive Insights
5.4.1 Market attractiveness
5.4.2 Competition heatmap
-
6. Pet Diabetes Care Market, By Cell Source
6.1. Overview
6.2 Glucose Monitoring Devices
6.2.1 Definition, key trends, growth factors, and opportunities
6.2.2 Market size analysis, by region, 2020-2027
6.2.3 Market share analysis, by country, 2020-2027
6.3 Insulin Delivery Devices
6.3.1 Definition, key trends, growth factors, and opportunities
6.3.2 Market size analysis, by region, 2020-2027
6.3.3 Market share analysis, by country, 2020-2027
6.4 Research Dive Exclusive Insights
6.4.1 Market attractiveness
6.4.2 Competition heatmap
-
7. Pet Diabetes Care Market, By Size By Level
7.1. Overview
7.2 Livestock
7.2.1 Definition, key trends, growth factors, and opportunities
7.2.2 Market size analysis, by region, 2020-2027
7.2.3 Market share analysis, by country, 2020-2027
7.3 Companion
7.3.1 Definition, key trends, growth factors, and opportunities
7.3.2 Market size analysis, by region, 2020-2027
7.3.3 Market share analysis, by country, 2020-2027
7.4 Research Dive Exclusive Insights
7.4.1 Market attractiveness
7.4.2 Competition heatmap
8. Pet Diabetes Care Market, By Region
8.1 North America
8.1.1 U.S
8.1.1.1 Market size analysis, By Product, 2020-2027
8.1.1.2 Market size analysis, By Cell Source, 2020-2027
8.1.1.3 Market size analysis, By Size by Level, 2020-2027
8.1.2 Canada
8.1.2.1 Market size analysis, By Product, 2020-2027
8.1.2.2 Market size analysis, By Cell Source, 2020-2027
8.1.2.3 Market size analysis, By Size by Level, 2020-2027
8.1.3 Mexico
8.1.3.1 Market size analysis, By Product, 2020-2027
8.1.3.2 Market size analysis, By Cell Source, 2020-2027
8.1.3.3 Market size analysis, By Size by Level, 2020-2027
8.1.4 Research Dive Exclusive Insights
8.1.4.1 Market attractiveness
8.1.4.2 Competition heatmap
8.2 Europe
8.2.1 Germany
8.2.1.1 Market size analysis, By Product, 2020-2027
8.2.1.2 Market size analysis, By Cell Source, 2020-2027
8.2.1.3 Market size analysis, By Size by Level, 2020-2027
8.2.2 UK
8.2.2.1 Market size analysis, By Product, 2020-2027
8.2.2.2 Market size analysis, By Cell Source, 2020-2027
8.2.2.3 Market size analysis, By Size by Level, 2020-2027
8.2.3 France
8.2.3.1 Market size analysis, By Product, 2020-2027
8.2.3.2 Market size analysis, By Cell Source, 2020-2027
8.2.3.3 Market size analysis, By Size by Level, 2020-2027
8.2.4 Spain
8.2.4.1 Market size analysis, By Product, 2020-2027
8.2.4.2 Market size analysis, By Cell Source, 2020-2027
8.2.4.3 Market size analysis, By Size by Level, 2020-2027
8.2.5 Italy
8.2.5.1 Market size analysis, By Product, 2020-2027
8.2.5.2 Market size analysis, By Cell Source, 2020-2027
8.2.5.3 Market size analysis, By Size by Level, 2020-2027
8.2.6 Rest of Europe
8.2.6.1 Market size analysis, By Product, 2020-2027
8.2.6.2 Market size analysis, By Cell Source, 2020-2027
8.2.6.3 Market size analysis, By Size by Level, 2020-2027
8.2.7 Research Dive Exclusive Insights
8.2.7.1 Market attractiveness
8.2.7.2 Competition heatmap
8.3 Asia-Pacific
8.3.1 China
8.3.1.1 Market size analysis, By Product, 2020-2027
8.3.1.2 Market size analysis, By Cell Source, 2020-2027
8.3.1.3 Market size analysis, By Size by Level, 2020-2027
8.3.2 Japan
8.3.2.1 Market size analysis, By Product, 2020-2027
8.3.2.2 Market size analysis, By Cell Source, 2020-2027
8.3.2.3 Market size analysis, By Size by Level, 2020-2027
8.3.3 India
8.3.3.1 Market size analysis, By Product, 2020-2027
8.3.3.2 Market size analysis, By Cell Source, 2020-2027
8.3.3.3 Market size analysis, By Size by Level, 2020-2027
8.3.4 Australia
8.3.4.1 Market size analysis, By Product, 2020-2027
8.3.4.2 Market size analysis, By Cell Source, 2020-2027
8.3.4.3 Market size analysis, By Size by Level, 2020-2027
8.3.5 South Korea
8.3.5.1 Market size analysis, By Product, 2020-2027
8.3.5.2 Market size analysis, By Cell Source, 2020-2027
8.3.5.3 Market size analysis, By Size by Level, 2020-2027
8.3.6 Rest of Asia-Pacific
8.3.6.1 Market size analysis, By Product, 2020-2027
8.3.6.2 Market size analysis, By Cell Source, 2020-2027
8.3.6.3 Market size analysis, By Size by Level, 2020-2027
8.3.7 Research Dive Exclusive Insights
8.3.7.1 Market attractiveness
8.3.7.2 Competition heatmap
8.4 LAMEA
8.4.1 Brazil
8.4.1.1 Market size analysis, By Product, 2020-2027
8.4.1.2 Market size analysis, By Cell Source, 2020-2027
8.4.1.3 Market size analysis, By Size by Level, 2020-2027
8.4.2 Saudi Arabia
8.4.2.1 Market size analysis, By Product, 2020-2027
8.4.2.2 Market size analysis, By Cell Source, 2020-2027
8.4.2.3 Market size analysis, By Size by Level, 2020-2027
8.4.3 UAE
8.4.3.1 Market size analysis, By Product, 2020-2027
8.4.3.2 Market size analysis, By Cell Source, 2020-2027
8.4.3.3 Market size analysis, By Size by Level, 2020-2027
8.4.4 South Africa
8.4.4.1 Market size analysis, By Product, 2020-2027
8.4.4.2 Market size analysis, By Cell Source, 2020-2027
8.4.4.3 Market size analysis, By Size by Level, 2020-2027
8.4.5 Rest of LAMEA
8.4.5.1 Market size analysis, By Product, 2020-2027
8.4.5.2 Market size analysis, By Cell Source, 2020-2027
8.4.5.3 Market size analysis, By Size by Level, 2020-2027
8.4.6 Research Dive Exclusive Insights
8.4.6.1 Market attractiveness
8.4.6.2 Competition heatmap
9. Competitive Landscape
9.1 Top winning strategies, 2020-2027
9.1.1 By strategy
9.1.2 By year
9.2 Strategic overview
9.3 Market share analysis, 2020-2027
10. Company Profiles
10.1 Allison Medical
10.1.1 Overview
10.1.2 Business segments
10.1.3 Product portfolio
10.1.4 Financial performance
10.1.5 Recent developments
10.1.6 SWOT analysis
10.2 Becton, Dickinson and Company
10.2.1 Overview
10.2.2 Business segments
10.2.3 Product portfolio
10.2.4 Financial performance
10.2.5 Recent developments
10.2.6 SWOT analysis
10.3 Boehringer Ingelheim (Boehringer Ingelheim Vetmedica Inc.)
10.3.1 Overview
10.3.2 Business segments
10.3.3 Product portfolio
10.3.4 Financial performance
10.3.5 Recent developments
10.3.6 SWOT analysis
10.4 Covetrus (Henry Schein Animal Health)
10.4.1 Overview
10.4.2 Business segments
10.4.3 Product portfolio
10.4.4 Financial performance
10.4.5 Recent developments
10.4.6 SWOT analysis
10.5 Merck & Co. Inc
10.5.1 Overview
10.5.2 Business segments
10.5.3 Product portfolio
10.5.4 Financial performance
10.5.5 Recent developments
10.5.6 SWOT analysis
10.6 MED TRUST
10.6.1 Overview
10.6.2 Business segments
10.6.3 Product portfolio
10.6.4 Financial performance
10.6.5 Recent developments
10.6.6 SWOT analysis
10.7 Taidoc Technology Corporation
10.7.1 Overview
10.7.2 Business segments
10.7.3 Product portfolio
10.7.4 Financial performance
10.7.5 Recent developments
10.7.6 SWOT analysis
10.8 UltiMed Inc.
10.8.1 Overview
10.8.2 Business segments
10.8.3 Product portfolio
10.8.4 Financial performance
10.8.5 Recent developments
10.8.6 SWOT analysis
10.9 Zoetis Inc
10.9.1 Overview
10.9.2 Business segments
10.9.3 Product portfolio
10.9.4 Financial performance
10.9.5 Recent developments
10.9.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
